pulmonary-disease

Documents about pulmonary-disease

• Efficacy of Liuzijue in Improving Respiratory Muscle Dysfunction in Chronic Obstructive Pulmonary Disease: Protocol for a Randomized Controlled Trial.#445929NCBI PubMed Central
• Risk Factors, Costs, and Impacts of ED Boarding#448188ClinicalTrials.gov
• Antibiotic or Not in Non-purulent Exacerbations of COPD: a Trial of Security and Efficacy#474791ClinicalTrials.gov
• Mucin expression in peripheral airways of patients with chronic obstructive pulmonary disease#625735Lund University Publications
• After Discharge Management of Low Income Frail Elderly#640470ClinicalTrials.gov
• Mitochondrial reprogramming of neutrophil extracellular traps in chronic obstructive pulmonary disease and asthma: toward a phenotype-driven therapeutic framework.#653387NCBI PubMed Central
• Deep Learning Image Reconstruction Algorithm for Quantitative Assessment of Low-Dose Biphasic Chest CT in Chronic Obstructive Pulmonary Disease.#662674NCBI PubMed Central
• Bioinformatics Screening and Preliminary Experimental Verification of Integrated Stress Response-Associated MYC and BAG3 in Chronic Obstructive Pulmonary Disease.#662675NCBI PubMed Central
• Clinical Evaluation of SenseGuard™ to Detect Respiratory Changes, During Home Monitoring of Subjects With High Risk of AECOPD.#802759ClinicalTrials.gov
• A Phase IIa, Randomized, Double-Blind, Placebo-Controlled Trial of JKN2403 in COPD#810770ClinicalTrials.gov
• Effects of VR Training on Balance and Fall Risk of Patients With COPD#827805ClinicalTrials.gov
• Study on Impact of Maximal Strength Training in Patients With COPD#832373ClinicalTrials.gov
• The Bern Rehab Registry#832672ClinicalTrials.gov
• Effects of Inhaled Corticosteroids on Sputum Bacterial Load in COPD#837809ClinicalTrials.gov
• A Retrospective Study Investigating the Factors Related to Non-tuberculous Mycobacterial Pulmonary Disease in Hong Kong#839919ClinicalTrials.gov
• Bioequivalence Study of Synflutide HFA Inhaler and Seretide Evohaler in Healthy Volunteers Without Charcoal Block#840196ClinicalTrials.gov
• Rehabilitation of People With Post-tuberculosis Lung Disease#848421ClinicalTrials.gov
• IVR-Enhanced Care Transition Support for Complex Patients#862131ClinicalTrials.gov
• Effects of a 9-months Treatment of SPIRIVA on Health Related Quality of Life in Patients With COPD#864032ClinicalTrials.gov
• Determining the Benefits of Improving Communication in BPAP/CPAP Users#868755ClinicalTrials.gov
• A Study to Investigate the Pharmacology of a Dual Pharmacophore in Healthy Volunteers#871427ClinicalTrials.gov
• A One Year Clinical Trial Assessing the Usefulness and Safety of Inhaled Insulin in Diabetics With COPD#878214ClinicalTrials.gov
• Integrated Radiographic and Metabolomics Risk Assessment in Patients With Interstitial Lung Diseases#878928ClinicalTrials.gov
• Corticosteroids and Hemoglobin A1C Levels in Diabetic Patients With COPD Exacerbation#883780ClinicalTrials.gov
• What is the most effective non-pharmacological treatment for poor sleep quality in Chronic obstructive pulmonary disease patients? a systematic review.#152128NCBI PubMed Central
• Triggered chain reaction: The meanings of symptom clusters for patients with chronic obstructive pulmonary disease: A cross-sectional qualitative study.#157864NCBI PubMed Central
• The Association Between Oral Microbiota and Chronic Obstructive Pulmonary Disease: An Integrated Study of Genetic Causal Inference and Bioinformatics Analysis#158294bioRxiv / medRxiv
• A Phase II, Randomized, Double-blind, Placebo-controlled Study to Assess MEDI3506 in Participants With COPD and Chronic Bronchitis#181824ClinicalTrials.gov
• Association Between Glucagon-Like Peptide-1 Receptor Agonists and Clinical Outcomes in Patients with Chronic Obstructive Pulmonary Disease and Obesity.#281183NCBI PubMed Central
• The role of glucagon-like peptide-1 receptor agonists and sodium-glucose cotransporter-2 inhibitors in chronic obstructive pulmonary disease#294980ScholarBank@NUS
• The Effect of Aromatherapy Massage on Pain, Anxiety and Comfort#343740ClinicalTrials.gov
• Bacterial topography of the respiratory tract, including pulmonary site-of-disease, in people with active tuberculosis: a case-control study#374136Europe PMC
• Serum acylcarnitine to amide ratio as a predictive biomarker for the progression of pulmonary disease caused by Mycobacterium avium complex#431799S-Space: Seoul National University
• Multimodal data driven machine learning approach for enhancing diagnostic accuracy and efficiency in pulmonary disease management within primary healthcare settings.#433873NCBI PubMed Central
• A Study of Mosliciguat in Combination With Inhaled Treprostinil in PH-ILD#441993ClinicalTrials.gov
• Individuals With Chronic Obstructive Pulmonary Disease Experience Lower Levels of Happiness Than Their Healthy Peers: A Case-Control Study.#457308NCBI PubMed Central
• Hemodynamic Effects of Inhaled Iloprost in PH-COPD (HOLLYWOOD)#471541ClinicalTrials.gov
• A tuberculosis school outbreak in China, 2018: reaching an often overlooked adolescent population.#684051eScholarship
• Prevalence and outcomes of pleuroparenchymal fibroelastosis in patients with non-tuberculous mycobacterial pulmonary disease: a French retrospective cohort study.#685701NCBI PubMed Central
• Smoking-induced EGF-dependent Reprogramming of Airway Basal Cell Function#803083ClinicalTrials.gov
• Randomised Trial of Telehealth Consultations for Nursing Care of Chronic Obstructive Pulmonary Disease (COPD) Patients#829707ClinicalTrials.gov
• Respiratory Support in Severe Chronic Obstructive Pulmonary Disease Exacerbation#834650ClinicalTrials.gov
• BDP/FF Versus Formoterol Fumarate (FF) in Patients With Severe COPD (Lung Function and Exacerbation Rate)#843901ClinicalTrials.gov
• Safety, Tolerability, and Clinical Activity of ASM-024 Administered to Patients With GOLD 2 or GOLD 3 Chronic Obstructive Pulmonary Disease (COPD)#846572ClinicalTrials.gov
• Changing Outcomes Through Achievement Emails in COPD Using Routine Healthcare Audits#847579ClinicalTrials.gov
• Tiotropium Once Daily 18 Mcg Versus Salmeterol Twice Daily 50 Mcg on Time to First Exacerbation in COPD Patients.#848968ClinicalTrials.gov
• Venous Disease Thromboembolic and Amyotrophic Lateral Sclerosis#849958ClinicalTrials.gov
• Effects of CPAP Level on Respiratory Mechanics and Central Drive in Patients With COPD#875823ClinicalTrials.gov
• Home Non Invasive Ventilation (NIV) Treatment for COPD-patients After a NIV-treated Exacerbation#833622ClinicalTrials.gov
• Rural Hospital-Level Care at Home for Acutely Ill Adults#121415ClinicalTrials.gov